Diagnostic uncertainty in a case of neuroleptic malignant syndrome

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Medicine

Background:

• Neuroleptic malignant syndrome (NMS) is a critical adverse reaction to antipsychotic medications.
• Standard diagnostic criteria often rely on fever and muscle rigidity, but atypical presentations occur.
• Diagnostic delays due to uncertainty can lead to severe patient outcomes.

Purpose of the Study:

• To describe an atypical case of NMS.
• To highlight diagnostic challenges associated with NMS.
• To examine limitations of current NMS diagnostic criteria and propose improvements.

Main Methods:

• Case report of an atypical NMS presentation.
• Review of existing NMS diagnostic criteria.
• Analysis of differential diagnoses for NMS.

Main Results:

• Atypical NMS presentations can occur without classic symptoms like fever or rigidity.
• The differential diagnosis for NMS is extensive, complicating diagnosis.
• Current diagnostic criteria may be insufficient for identifying all NMS cases.

Conclusions:

• Atypical NMS presentations pose significant diagnostic challenges.
• Current diagnostic criteria for NMS require re-evaluation.
• Revised criteria are needed to ensure timely and accurate NMS diagnosis and management.